Atticus Wealth Management, LLC
- SEC CIK
- 0001800234
- Latest filing
- Jul 15, 2026
MBRX holding history
Moleculin Biotech, Inc. in every 13F filed by Atticus Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MBRX overviewAll 13F holders of MBRXFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −2,784−100.0% | Sold out | Holders |
| Q4 2024 | 2,784 | $4.73K | <0.1% | −550−16.5% | Reduced | Holders |
| Q3 2024 | 3,334 | $9.47K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3,334 | $11.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3,334 | $19.7K | <0.1% | 00.0% | UnchangedConverted for a 1-for-15 split | Holders |
| Q4 2023 | 50,001 | $42.9K | <0.1% | +50,001 | New | Holders |